Key facts
- This page summarizes Florian Brand's Form 4 filing for ATAI Life Sciences N.V. (ATAI).
- 6 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 04 Oct 2024, 16:30.
Florian Brand - 04 Oct 2024 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)
- Reporting relationship
- Co-Founder & Co-Chief Executive Officer
- Issuer ticker
- ATAI
- Reported as of
- 04 Oct 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Oct 2024, 16:30:10 UTC
- Prior SEC filing
- 20 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ryan Barrett, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Florian Brand filed Form 4 for ATAI Life Sciences N.V. (ATAI) on 04 Oct 2024.
Change
- Previous filing in this sequence was filed on 20 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATAI
transaction
Derivative
Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -4,240,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 4,240,000
- Exercise price
- $0.3700
- Footnotes
- F1, F2
ATAI
transaction
Derivative
Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -400,688
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 400,688
- Exercise price
- $5.68
- Footnotes
- F1, F2
ATAI
transaction
Derivative
Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -338,112
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 338,112
- Exercise price
- $11.71
- Footnotes
- F1, F3
ATAI
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +4,240,000
- Change %
- Price
- Shares after
- 4,240,000
- Date
- 04 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 4,240,000
- Exercise price
- $0.3700
- Footnotes
- F1, F2
ATAI
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +400,688
- Change %
- Price
- Shares after
- 400,688
- Date
- 04 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 400,688
- Exercise price
- $5.68
- Footnotes
- F1, F2
ATAI
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +338,112
- Change %
- Price
- Shares after
- 338,112
- Date
- 04 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 338,112
- Exercise price
- $11.71
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
No new stock options have been awarded. The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options previously awarded subject to performance conditions that were not satisfied at the time of the Issuer's IPO but have subsequently been satisfied to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.
Footnote F2
The stock option is fully vested and currently exercisable.
Footnote F3
The stock option vested as to 25% of the underlying shares on April 29, 2022, and the remaining underlying shares vest in 36 substantially equal monthly installments thereafter.
SEC remarks
Co-Founder & Co-Chief Executive Officer